Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS)
Background: In December 2019, pneumonia associated with a novel coronavirus (COVID-19) was reported in Wuhan, China. Acute respiratory distress syndrome (ARDS) is the most frequently observed complication in COVID-19 patients with high mortality rates. Objective of study: To observe the clinical eff...
Guardado en:
Autores principales: | Seyed MohammadReza Hashemian, Navid Shafigh, Golnaz Afzal, Hamidreza Jamaati, Payam Tabarsi, Majid Marjani, Majid Malekmohammad, Seyed Mehdi Mortazavi, Batoul Khoundabi, Davood Mansouri, Afshin Moniri, Abbas Hajifathali, Elham Roshandel, Esmaeil Mortaz, Ian M Adcock |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier España
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/251c71fa0b174c62b8732e1118d1ffd1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Plasmapheresis in the Treatment of Refractory Myoclonic Status. A Case Report
por: Gutierrez-Gutierrez Judit, et al.
Publicado: (2021) -
Potential diagnostic value of pleural fluid cytokines levels for tuberculous pleural effusion
por: Neda Dalil Roofchayee, et al.
Publicado: (2021) -
Levels of the TNF-Related Cytokine LIGHT Increase in Hospitalized COVID-19 Patients with Cytokine Release Syndrome and ARDS
por: David S. Perlin, et al.
Publicado: (2020) -
Uso de plasmaféresis en unidades de pacientes críticos
por: Benítez G,Carlos, et al.
Publicado: (2005) -
Effect of INTELLiVENT-ASV versus Conventional Ventilation on Ventilation Intensity in Patients with COVID-19 ARDS—An Observational Study
por: Laura A. Buiteman-Kruizinga, et al.
Publicado: (2021)